| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,069 | 0,090 | 25.10. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.09. | HVIVO Slides To Loss In H1 | - | RTTNews | ||
| 23.09. | hVIVO PLC - Interim results | - | RNS | ||
| 04.09. | hVIVO PLC - Notice of Results | 4 | RNS | ||
| 01.09. | hVIVO appoints Avacta Chair Shaun Chilton to lead board | 1 | Alliance News | ||
| 01.09. | hVIVO PLC - Appointment of Non-Executive Chair | - | RNS | ||
| 29.07. | hVIVO PLC - Proposed appointment of Chair | - | RNS | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 22.07. | hVIVO PLC - H1 Trading update | 1 | RNS | ||
| 18.07. | hVIVO PLC - Directorate Change | - | RNS | ||
| 09.07. | hVIVO PLC - Notice of Trading Update | - | RNS | ||
| 30.06. | hVivo reports positive results from its largest lab contract to date | 1 | Sharecast | ||
| 30.06. | hVIVO reports positive results from Cidara's Phase 2b influenza study | 3 | Investing.com | ||
| 30.06. | hVIVO PLC - Positive results from client Phase 2b field study | - | RNS | ||
| 05.06. | hVIVO PLC - Result of AGM | - | RNS | ||
| 02.06. | hVIVO PLC - Director/PDMR Shareholding | - | RNS | ||
| 30.05. | Hvivo client cancels 'significant' HCT trial contract | 1 | Sharecast | ||
| 30.05. | hVIVO PLC - Trading update | - | RNS | ||
| 29.05. | hVIVO PLC - Appointment of Independent Non-Executive Director | - | RNS | ||
| 12.05. | hVIVO announces annual report and upcoming AGM | 1 | Investing.com | ||
| 12.05. | hVIVO kündigt Jahresbericht und kommende Hauptversammlung an | 1 | Investing.com Deutsch | ||
| 12.05. | hVIVO PLC - Annual Report, Notice of AGM & Directorate Change | - | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,611 | -3,83 % | Plus Therapeutics Inc.: Plus Therapeutics Updates on CNSide Diagnostic Platform Launch | ||
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| JD HEALTH INTERNATIONAL | 6,950 | 0,00 % | JD HEALTH Forms In Vitro Diagnostics Alliance with Multiple IVD Brands | ||
| LIFEWARD | 0,648 | -0,31 % | Lifeward Ltd.: Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| EKSO BIONICS | 5,020 | +3,08 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 4,140 | -1,43 % | IMUNON präsentiert auf SITC-Tagung neue Daten zur Eierstockkrebs-Therapie | ||
| BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
| ROCKWELL MEDICAL | 0,991 | -0,65 % | Rockwell Medical promotes Heather Hunter to COO | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| VIRIDIAN THERAPEUTICS | 19,140 | +0,47 % | Viridian Therapeutics prices $251M share offering | ||
| SINTX TECHNOLOGIES | 3,750 | +8,07 % | SiNtx Technologies, Inc.: SINTX Technologies erhält FDA-Zulassung für SINAPTIC Fuß- und Sprunggelenk-Implantatsystem | Das von der FDA zugelassene und in den USA hergestellte Implantatsystem positioniert SINTX für den Eintritt in den milliardenschweren US-Markt
SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| AETHLON MEDICAL | 0,540 | 0,00 % | XFRA EJU1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAETHL.MED. OCT.25... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.08.2025.ISIN NameAU000000DHG9 DOMAIN... ► Artikel lesen | |
| SAVARIA | 13,500 | -0,74 % | Savaria Corporation declares CAD 0.0467 dividend | ||
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report |